Annual EBITDA
-$119.02 M
+$36.23 M+23.34%
31 December 2023
Summary:
HilleVax annual earnings before interest, taxes, depreciation & amortization is currently -$119.02 million, with the most recent change of +$36.23 million (+23.34%) on 31 December 2023. During the last 3 years, it has fallen by -$116.94 million (-5638.57%). HLVX annual EBITDA is now -5638.57% below its all-time high of -$2.07 million, reached on 31 December 2020.HLVX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$23.13 M
+$16.01 M+40.90%
30 September 2024
Summary:
HilleVax quarterly earnings before interest, taxes, depreciation & amortization is currently -$23.13 million, with the most recent change of +$16.01 million (+40.90%) on 30 September 2024. Over the past year, it has increased by +$7.32 million (+24.03%). HLVX quarterly EBITDA is now -1404.75% below its all-time high of -$1.54 million, reached on 31 March 2021.HLVX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$143.17 M
+$7.32 M+4.86%
30 September 2024
Summary:
HilleVax TTM earnings before interest, taxes, depreciation & amortization is currently -$143.17 million, with the most recent change of +$7.32 million (+4.86%) on 30 September 2024. Over the past year, it has dropped by -$39.04 million (-37.49%). HLVX TTM EBITDA is now -9214.77% below its all-time high of -$1.54 million, reached on 31 March 2021.HLVX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HLVX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.3% | +24.0% | -37.5% |
| 3 y3 years | -5638.6% | +34.3% | -43.8% |
| 5 y5 years | - | - | - |
HLVX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5638.6% | +23.3% | -42.8% | +64.9% | -59.3% | +33.4% |
| 5 y | 5 years | -5638.6% | +23.3% | -1404.8% | +64.9% | -9214.8% | +33.4% |
| alltime | all time | -5638.6% | +23.3% | -1404.8% | +64.9% | -9214.8% | +33.4% |
HilleVax EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.13 M(-40.9%) | -$143.17 M(-4.9%) |
| June 2024 | - | -$39.13 M(-13.8%) | -$150.49 M(+8.8%) |
| Mar 2024 | - | -$45.40 M(+27.8%) | -$138.33 M(+16.2%) |
| Dec 2023 | -$119.02 M(-23.3%) | -$35.51 M(+16.6%) | -$119.02 M(+14.3%) |
| Sept 2023 | - | -$30.45 M(+12.8%) | -$104.13 M(+15.9%) |
| June 2023 | - | -$26.98 M(+3.5%) | -$89.88 M(-22.2%) |
| Mar 2023 | - | -$26.08 M(+26.5%) | -$115.52 M(-25.6%) |
| Dec 2022 | -$155.25 M | -$20.62 M(+27.3%) | -$155.25 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$16.20 M(-69.2%) | -$169.84 M(-20.9%) |
| June 2022 | - | -$52.62 M(-20.0%) | -$214.80 M(+31.1%) |
| Mar 2022 | - | -$65.81 M(+86.9%) | -$163.84 M(+64.6%) |
| Dec 2021 | -$99.56 M(+4700.4%) | - | - |
| Dec 2021 | - | -$35.22 M(-42.4%) | -$99.56 M(+54.7%) |
| Sept 2021 | - | -$61.15 M(+3586.0%) | -$64.35 M(+1913.4%) |
| June 2021 | - | -$1.66 M(+7.9%) | -$3.20 M(+107.9%) |
| Mar 2021 | - | -$1.54 M | -$1.54 M |
| Dec 2020 | -$2.07 M | - | - |
FAQ
- What is HilleVax annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for HilleVax?
- What is HilleVax annual EBITDA year-on-year change?
- What is HilleVax quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for HilleVax?
- What is HilleVax quarterly EBITDA year-on-year change?
- What is HilleVax TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for HilleVax?
- What is HilleVax TTM EBITDA year-on-year change?
What is HilleVax annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of HLVX is -$119.02 M
What is the all time high annual EBITDA for HilleVax?
HilleVax all-time high annual earnings before interest, taxes, depreciation & amortization is -$2.07 M
What is HilleVax annual EBITDA year-on-year change?
Over the past year, HLVX annual earnings before interest, taxes, depreciation & amortization has changed by +$36.23 M (+23.34%)
What is HilleVax quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of HLVX is -$23.13 M
What is the all time high quarterly EBITDA for HilleVax?
HilleVax all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.54 M
What is HilleVax quarterly EBITDA year-on-year change?
Over the past year, HLVX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$7.32 M (+24.03%)
What is HilleVax TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of HLVX is -$143.17 M
What is the all time high TTM EBITDA for HilleVax?
HilleVax all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.54 M
What is HilleVax TTM EBITDA year-on-year change?
Over the past year, HLVX TTM earnings before interest, taxes, depreciation & amortization has changed by -$39.04 M (-37.49%)